EMAIL THIS PAGE TO A FRIEND

Biological & pharmaceutical bulletin

A Nanoparticle-Based Ophthalmic Formulation of Dexamethasone Enhances Corneal Permeability of the Drug and Prolongs Its Corneal Residence Time.


PMID 28674248

Abstract

We designed ophthalmic formulations containing dexamethasone-loaded solid nanoparticles (DEX